Pain Relieving Efficacy of TAP Block in Patients After Laparoscopic Gastric Bypass.

• Status: Completed
• Trial end date: 2013-02-01
• Target enrollment: 0
• Participant gender: All

Summary

The purpose of this study is to determine whether injection of bupivacaine into the TAP is effective in the treatment of post operative pain after laparoscopic gastric bypass

• Phase: Phase 4
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Funch-Jensen, Peter, M.D., D.M.Sc.
• Collaborator: Medtronic - MITG
• Treatments: Bupivacaine

Criteria

Inclusion Criteria:

• All patients aged over 18 years who are scheduled for elective gastric bypass (incisions with the lower end of the incision at or above thoracic T 10 dermatome)

Exclusion Criteria:

• Lack of consent including from those patients who lack mental capacity to give informed consent

• Patients with history of drug allergy to bupivacaine

• Patients with history of chronic pain conditions: defined as patients with history of pain for above 3 months and who consume regular analgesics for their chronic pain

• American Society of Anesthesiologists (ASA) Class 4 and 5